FDA to take action on companies marketing 'illegal copycat drugs', FDA chief says
I'm PortAI, I can summarize articles.
The FDA plans to take action against companies marketing illegal copycat drugs that mimic FDA-approved products. Commissioner Marty Makary highlighted concerns over Hims and Hers Health's unapproved $49 version of Novo Nordisk's Wegovy weight-loss pill, emphasizing the lack of verified quality and safety for non-approved drugs. Following the announcement, Hims' shares fell by 4.7% in after-hours trading.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments